Flex Work policy
Corporate Policy
Full time in office
About
Atalanta Therapeutics, founded in 2018, is a biotechnology company specializing in the development of siRNA therapeutics for neurodegenerative and genetic diseases like Huntington’s, Alzheimer’s, and Parkinson’s disease. The company's mission is to leverage their innovative RNA interference (RNAi) technology to slow disease progression and improve patients' quality of life. Headquartered in Boston, Massachusetts, this three-year-old company is dedicated to generating transformative therapies for challenging diseases.
This content was generated by A.I. Atalanta Therapeutics employees can
to make any changes.